Index Investing News
Sunday, May 24, 2026
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Nike, Micron, Amylyx and others

by Index Investing News
October 2, 2022
in Stocks
Reading Time: 2 mins read
A A
0
Home Stocks
Share on FacebookShare on Twitter


Check out the companies making headlines before the bell:

Nike (NKE) – Nike slumped 10% in the premarket after it reported a 44% increase in inventories for its latest quarter, and said it would offer more discounts heading into the holiday season. The athletic footwear and apparel maker reported better-than-expected profit and revenue for its latest quarter.

Micron Technology (MU) – Micron gained 1.5% in the premarket after it beat estimates with its latest quarterly earnings, even as sales fell below forecasts. The chipmaker also issued a weaker-than-expected revenue outlook and said sales are being impacted by waning demand for consumer electronics.

Amylyx Pharmaceuticals (AMLX) – Amylyx surged 9.3% in the premarket after the FDA approved its new ALS drug. The treatment slows the progression of the disease, extends survival, and is the first ALS drug to gain FDA approval in five years.

Rent-A-Center (RCII) – Rent-A-Center tumbled 18.1% in the premarket after the rent-to-own company cut its current-quarter earnings guidance. The company said current economic conditions have impacted retail traffic and customer payment patterns.

Blue Apron (APRN) – The meal kit company’s shares initially fell in premarket action following news that Chief Financial Officer Randy Greben will step down on October 17 to take a position with another company. However, it subsequently erased those losses and rose 2.7%.

Generac (GNRC) – Generac added 1.6% in premarket trading after Cowen began coverage on the power equipment maker with an outperform rating. Cowen said a housing market slowdown and economic uncertainty are already priced into the stock.

Voya Financial (VOYA) – The financial services company’s stock was upgraded to overweight from neutral at Piper Sandler, citing a number of factors including attractive valuation and a product portfolio that benefits from inflation. Voya added 1.2% in premarket action.



Source link

Tags: AmylyxMicronNike
ShareTweetShareShare
Previous Post

Wait ‘Til The VIX Spikes

Next Post

The cost of electric bills to cool some houses in a heat wave

Related Posts

Lululemon: The Sell-Off Is Overdone, But Don’t Fall In Love With The Stock (NASDAQ:LULU)

Lululemon: The Sell-Off Is Overdone, But Don’t Fall In Love With The Stock (NASDAQ:LULU)

by Index Investing News
May 23, 2026
0

This article was written byFollowI am an investment professional with over 7 years of experience spanning quant equities, asset management,...

Friday File: Portfolio Construction in a Time of Greed and Fear

Friday File: Portfolio Construction in a Time of Greed and Fear

by Index Investing News
May 19, 2026
0

Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a...

Berkshire shares trade lower even after Abel scores good marks at meeting, earnings jump

Berkshire shares trade lower even after Abel scores good marks at meeting, earnings jump

by Index Investing News
May 11, 2026
0

Greg Abel, CEO of Berkshire Hathaway, speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska, May 2, 2026.CNBCBerkshire...

The S&P 500 Dividend Yield Just Hit An All-Time Low – Meb Faber Research

The S&P 500 Dividend Yield Just Hit An All-Time Low – Meb Faber Research

by Index Investing News
May 7, 2026
0

The S&P 500 dividend yield just hit an all-time low of 1.08%, the lowest since the 1800s. The prior low...

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline By Reuters

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline By Reuters

by Index Investing News
April 29, 2026
0

By Kamal Choudhury and Christy Santhosh April 29 (Reuters) - on Wednesday reported better-than-expected quarterly revenue and profit, fueled by...

Next Post
The cost of electric bills to cool some houses in a heat wave

The cost of electric bills to cool some houses in a heat wave

L.A. ‘mansion tax’ would raise money for affordable housing

L.A. 'mansion tax' would raise money for affordable housing

RECOMMENDED

‘I don’t think he’s bluffing’ : worldnews

‘I don’t think he’s bluffing’ : worldnews

September 25, 2022
Apple TV+ is providing a free preview of their service this weekend

Apple TV+ is providing a free preview of their service this weekend

January 1, 2025
Top Wall Street analysts pound the table on stocks like Amazon

Top Wall Street analysts pound the table on stocks like Amazon

August 20, 2023
VOX: High-Beta On Once Again After Fed Pause, Forward Earnings Projections (NYSEARCA:VOX)

VOX: High-Beta On Once Again After Fed Pause, Forward Earnings Projections (NYSEARCA:VOX)

November 4, 2023
Prime Wall Avenue analysts favor these 3 shares for the long run

Prime Wall Avenue analysts favor these 3 shares for the long run

March 16, 2025
MTA: Peter Borish, Tudor Investments

MTA: Peter Borish, Tudor Investments

April 28, 2023
Discover of Delisting and Re-Compliance of Nasdaq Itemizing Rule By Investing.com

Discover of Delisting and Re-Compliance of Nasdaq Itemizing Rule By Investing.com

November 30, 2024
Applaud pope’s name for mercy –
Las Vegas Solar Information

Applaud pope’s name for mercy – Las Vegas Solar Information

May 16, 2025
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In